RUSH Copley Recognized for Excellence in Lung Cancer Screening

Cancer Care Center awarded for commitment to early detection
Looking at a picture of a lung screening

RUSH Copley Cancer Care Center has earned recognition as a Center of Excellence by GO2 for Lung Cancer for providing the Fox Valley community with patient-centered, evidence-based lung cancer screening. All three RUSH hospitals have been awarded this designation, which connects them to a nationwide network of other Centers of Excellence. 

All GO2-designated Centers of Excellence are committed to keeping patients at the heart of every decision across the entire care pathway, while their lung cancer screening is in accordance with current evidence and clinical guidelines developed by organizations such as the American College of Radiology and the National Comprehensive Cancer Network.

“We’re dedicated to providing our patients with the highest quality care,” said Judi Bonomi, director, Cancer Care and Inpatient Nursing at RUSH Copley. “We use a multidisciplinary clinical process to coordinate patient follow-up, diagnostics and transition to treatment. And our low-dose CT screening is currently the only proven method to detect lung cancer at the earliest stage. We are thrilled to be part of this elite group, setting an example for responsible screening practices across the country.”

An estimated 237,000 Americans are diagnosed with lung cancer annually, with most being found at an advanced stage of the disease, according to GO2. As a result, lung cancer has long been the leading cause of cancer deaths in the U.S. — which underscores the importance of low-dose CT screening. 

“After decades of study, the oncology community understands that low-dose CT screening for individuals at high risk for lung cancer is clearly the most effective diagnostic tool for detecting the disease early, when the disease is most treatable and even curable,” said RUSH thoracic surgeon Justin Karush, DO, who sees patients in Aurora, Chicago and New Lenox. “In fact, according to the American Lung Association, if early-stage lung cancer is caught before it spreads, the likelihood of surviving five years or more improves to 63%.” 

GO2 for Lung Cancer Centers of Excellence is national in scope and local in impact. Across the U.S., the majority of people living with lung cancer are served by a local community hospital near their home. The GO2 COE network of community hospitals, clinics, and academic and VA medical centers collaborate and share their knowledge to bring national and global advancements in early detection, treatment and care close to home.

Learn more about lung cancer screening at RUSH.

Related Stories